SEBRA Sepsis and Bacterial Resistance Alliance
111 – 120 of 292
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
A pharmacoproteomic landscape of organotypic intervention responses in Gram-negative sepsis
- Contribution to journal › Article
-
Mark
Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineering
- Contribution to journal › Letter
-
Mark
Subclass-switched anti-Spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization
- Contribution to journal › Article
-
Mark
A human monoclonal antibody bivalently binding two different epitopes in streptococcal M protein mediates immune function
- Contribution to journal › Article
-
Mark
Cardiac Arrest Treatment Center Differences in Sedation and Analgesia Dosing During Targeted Temperature Management
- Contribution to journal › Article
-
Mark
Use of healthcare before and after sepsis in Sweden : a case-control study
- Contribution to journal › Article
-
Mark
Small-molecule-mediated OGG1 inhibition attenuates pulmonary inflammation and lung fibrosis in a murine lung fibrosis model
- Contribution to journal › Article
-
Mark
Proteogenomics decodes the evolution of human ipsilateral breast cancer
- Contribution to journal › Article
-
Mark
Group A streptococci induce stronger M protein-fibronectin interaction when specific human antibodies are bound
- Contribution to journal › Article
-
Mark
Protective non-neutralizing mAbs Ab94 and Ab81 retain high-affinity and potent Fc-mediated function against SARS-CoV-2 variants from Omicron to XBB1.5
(2023)
- Working paper/Preprint › Preprint in preprint archive
